Upper Respiratory Tract Infection Treatment Market is estimated to be US$ 2.5 billion by 2032: Increasing Prevalence of Lung Diseases to Propel Market Growth
In response to the growing demand for upper respiratory tract infection (URTI) treatments, the pharmaceutical industry is witnessing significant advancements. […]